19/03/2026 - Campus Can Ruti, Innovation

Banc de Sang i Teixits hosts an Innomed meeting to share capabilities in advanced therapies

The Innomed community visited the Banc de Sang i Teixits (BST) yesterday as part of a new meeting organised within the framework of the Innomed programme, led by the Germans Trias i Pujol Research Institute (IGTP), with the aim of strengthening connections between research institutions, hospitals and organisations within the biomedical ecosystem, and exploring new opportunities for collaboration in the field of advanced therapies and health innovation.

10/03/2026 - Campus Can Ruti, Conferences, Innovation, Projects

IGTP takes part in the innovation ecosystem of the Mobile World Congress 2026

IGTP took part in the 2026 edition of MWC and 4YFN with professionals and spin-offs from the institute, showcasing projects in health innovation and strengthening its role in connecting biomedical research with companies, investors and institutions to advance technologies with potential clinical and societal impact.

23/12/2025 - Campus Can Ruti, Research

Germans Trias Hospital launches the first screening program in Catalonia to detect type 1 diabetes before the onset of symptoms

Early diagnosis can help prevent serious complications, reduce hospital admissions and minimise the impact of disease onset in children and adolescents

06/11/2025 - Campus Can Ruti, Conferences, Institutional

Awards for Research Career in Primary Care and for Best Article at the 16th Conference of Institut Català de la Salut, focused on cancer

The conference has been a meeting point and an opportunity to share strategies, knowledge and innovative projects that contribute to improving the health and quality of life of people affected by cancer. Pere Torán and Federico Fondelli, researchers affiliated with IGTP, have been recognised in the 2025 Research Awards.

30/05/2025 - Campus Can Ruti, Outreach, Success Stories

IGTP’s podcast launches a new episode dedicated to multiple sclerosis

The episode features Eva Martínez-Cáceres and Cristina Ramo. Together, they explain the basics of multiple sclerosis and the research they are conducting. The episode also includes the testimony of a patient, who shares what it is like to live with the disease.

19/11/2024 - Campus Can Ruti, Outreach

Can Ruti welcomes students from Badalona for the Science Week

Nearly 200 baccalaureate and vocational training students from the Badalona institutes visited the centres at the Can Ruti Campus. The event "Open House, get to know the Can Ruti Campus up close", organised by the Badalona Education Service and IGTP, in coordination with other institutions on the Campus, has become a flagship initiative of the Science Week.

03/10/2024 - Campus Can Ruti, Research

New study finds a promising combined therapy for multiple sclerosis

Researchers from Barcelona's Germans Trias i Pujol Institute and Josep Carreras Leukaemia Research Institute have found a potential new way to improve the treatment of multiple sclerosis (MS) using a novel combined therapy. The results, published in the Journal of Clinical Investigation, builds on two harmonized Phase I clinical trials funded by the European Union, focusing on the use of Vitamin D3 tolerogenic dendritic cells (VitD3-tolDCs) to regulate the immune response in MS patients. The team is now preparing to move into Phase II trials to further explore these findings.

21/12/2022 - Innovation, Projects, Research

Two IGTP projects, financed with 1.6 million euros by the European Commission

The European Commission has granted two projects to the IGTP within the HORIZON programme, which add up to a total of 1,670,346 euros in funding and deal with the preclinical development of immunotherapies.

05/03/2021 - Research

New insights into the mechanisms of how tolerogenic therapies reduce aggressive immune activity in treatments for auto-immune and inflammatory diseases

The Immunopathology research group with the Immunology service and the Multiple Sclerosis Unit at the Germans Trias i Pujol Hospital and Institute continue their research to develop treatments for multiple sclerosis (MS). Their latest paper published in Frontiers of Immunology, examines the mechanisms by which vitamin D3-dendritic cells are used to alter a patient's own lymphocytes so they can be used to inhibit autoimmune responses.

04/08/2020 - Research

The IGTP cytometry core facility is a reference for spectral cytometry in Europe

The Cytometry core facility, headed by Dr Marco Antonio Fernández, is one of the 9 European laboratories developing multidimensional panels for spectral cytometry to study the immune response to COVID-19 with the company Cytek Biosciences. Now the IGTP is one of the reference centres in this technology, the result of work in laboratories in Holland, the United Kingdom, France, Germany and Spain.